Skip to content Skip to footer
Subscribe Now
EXCLUSIVE

Exclusive Interview with PharmaShots: Moshe Safran of RSIP Vision Share Insight on the 3D Reconstruction Technology

In an interview with PharmaShots, Moshe Safran, CEO at RSIP Vision shared his views on the new coronary module in the complete 3D reconstruction of the coronary vasculature during angiography Shots: The company reported the 3D reconstruction technology that focused on AI to generate 3D models of patient anatomy from 2D images. The purpose of the technology is to create precise,…
February 7, 2022

Read more

Viewpoints_Laura Dix
VIEWPOINTS

PharmaShots Interview: Accenture Life Sciences’ Laura Dix Shares Insights on the New Rules of Engagement to Provide HCPs New Interactions

In an interview with PharmaShots, Laura Dix, a Managing Director in Accenture’s Life Sciences Strategy and Consulting practice shares her views on the new research & provides more useful, data-driven information to HCPs  Shots: The company unveiled new research, titled The “New” Rules of Engagement & which have increased their relevance during COVID-19 through more valuable and meaningful interactions with…
February 2, 2022

Read more

Viewpoints_Laurent Levy
VIEWPOINTS

PharmaShots Interview: Nanobiotix’s Laurent Levy Shares Insights on the P-III (NANORAY-312) Study of NBTXR3 for the Treatment of Head and Neck Squamous Cell Carcinoma

In an interview with PharmaShots, Laurent Levy, Co-Founder & CEO at Nanobiotix shares his views on the first patient enrollment of NBTXR3 in P-III (NANORAY-312) study for the treatment of head and neck squamous cell carcinoma Shots: The first patient has been enrolled in P-III (NANORAY-312) study to evaluate the efficacy & safety of NBTXR3 with/out cetuximab vs radiotherapy with/out cetuximab…
January 31, 2022

Read more

Spotlight Interview_Michael Sassano
SPOTLIGHT

Spotlight Interview with Michael Sassano, CEO and Chairman of the Board for Somai Pharmaceuticals

On February 01, 2022, PharmaShots will present the second interview in its new interview section, “Spotlight- Company of the Month’’. Company of the month is our new exclusive feature under which we are interviewing the key leaders of the start-ups that are providing fierce solutions. We pick one company every month and interview them about…
January 27, 2022

Read more

Viewpoints_Ilse Eder
VIEWPOINTS

PharmaShots Interview: E&E CRO Consulting’s Ilse Eder Shares Insights on the Trends of Clinical Research & New Healthcare Technologies

In an interview with PharmaShots, Ilse Eder, CEO at E&E CRO Consulting shares her views on the breakthrough healthcare technologies to improve patient outcomes Shots: Principal Technologies is an investor in the MedTech space. Its first investment is an 80% stake in E&E which is focused on helping companies earn international distribution permits via clinical studies  Principal Technologies focuses on identifying…
January 25, 2022

Read more

Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas
INSIGHTS+

Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas

Shots: The 40th Annual J.P. Morgan Healthcare Conference took place virtually on Jan 10-13, 2022. The premier conference is the most extensive and most informative health care investment symposium in the Healthcare and pharma sector, which connects global leaders, emerging companies, innovative technology creators, and members of the investment community Considering the top biopharma companies…
January 19, 2022

Read more

Viewpoints_Thomas C. Corbridge
VIEWPOINTS

PharmaShots Interview: GSK’s Thomas C. Corbridge Shares Insights on the New Survey Data for Severe Eosinophilic Asthma Patients

In an interview with PharmaShots, Thomas C. Corbridge, US Senior Medical Lead at GSK shares his views on the new survey and demonstrated dissatisfaction with the asthma treatment paradigm Shots: The survey was commissioned by GSK and conducted by The Harris Poll in 100 patients aged ≥18yrs. showed that a majority of SEA patients and physicians are concerned about the current state…
January 18, 2022

Read more

Load more